estrone has been researched along with cyproterone acetate in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (41.67) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Austin, CP; Fidock, DA; Hayton, K; Huang, R; Inglese, J; Jiang, H; Johnson, RL; Su, XZ; Wellems, TE; Wichterman, J; Yuan, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Brailly, S; Couzinet, B; Le Strat, N; Schaison, G | 1 |
| Bulletti, C; Ciotti, P; Flamigni, C; Franceschetti, F; Jasonni, VM; Marabini, A; Naldi, S; Vignudelli, A | 1 |
| Christiansen, C; Jensen, J; Jensen, PB; Riis, BJ; Rødbro, P; Strøm, V | 1 |
| Couzinet, B; Schaison, G | 1 |
| Christiansen, C; Jensen, J | 1 |
| Abramovici, Y; Boudou, P; Cathelineau, G; Conard, J; Consoli, S; Fiet, J; Hardy, N; Vexiau, P | 1 |
| Caruso, A; De Leo, V; Fulghesu, AM; la Marca, A; Morgante, G; Pasqui, L; Talluri, B; Torricelli, M | 1 |
6 trial(s) available for estrone and cyproterone acetate
| Article | Year |
|---|---|
Comparative effects of cyproterone acetate or a long-acting gonadotropin-releasing hormone agonist in polycystic ovarian disease.
Topics: Adult; Androstane-3,17-diol; Androstenedione; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Polycystic Ovary Syndrome; Testosterone; Triptorelin Pamoate | 1986 |
Climacteric symptoms after oral and percutaneous hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Climacteric; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Double-Blind Method; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Middle Aged; Progesterone | 1987 |
Comparative effects of cyproterone acetate or a long-acting LHRH agonist in polycystic ovarian disease.
Topics: Adult; Androgens; Clinical Trials as Topic; Cyproterone; Cyproterone Acetate; Delayed-Action Preparations; Estradiol; Estrone; Female; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Random Allocation; Triptorelin Pamoate | 1987 |
Effects of smoking on serum lipoproteins and bone mineral content during postmenopausal hormone replacement therapy.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Bone and Bones; Cholesterol, HDL; Cholesterol, LDL; Cyproterone; Cyproterone Acetate; Drug Combinations; Estradiol; Estrogens; Estrone; Female; Gels; Humans; Lipoproteins; Menopause; Middle Aged; Minerals; Pregnancy; Smoking | 1988 |
17 beta-Estradiol: oral or parenteral administration in hyperandrogenic women? Metabolic tolerance in association with cyproterone acetate.
Topics: Administration, Cutaneous; Administration, Oral; Angiotensinogen; Antithrombin III; Apolipoproteins; Blood Coagulation; Blood Glucose; Blood Pressure; Cholesterol; Cholesterol, HDL; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrone; Female; Fibrinogen; Fibrinolysis; Glucose Tolerance Test; Humans; Hyperandrogenism; Insulin; Plasminogen; Premenopause; Prospective Studies; Sex Hormone-Binding Globulin | 1995 |
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism.
Topics: Adult; Amenorrhea; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone Acetate; Estradiol; Estradiol Congeners; Estrone; Ethinyl Estradiol; Female; Flutamide; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Hirsutism; Humans; Luteinizing Hormone; Luteolytic Agents; Polycystic Ovary Syndrome; Progesterone Congeners; Prospective Studies; Triptorelin Pamoate | 2000 |
6 other study(ies) available for estrone and cyproterone acetate
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Topics: Animals; Antimalarials; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Mapping; Crosses, Genetic; Dihydroergotamine; Drug Design; Drug Resistance; Humans; Inhibitory Concentration 50; Mutation; Plasmodium falciparum; Quantitative Trait Loci; Transfection | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Treatment of endometrial hyperplasia with cyproterone acetate histological and hormonal aspects.
Topics: Androgen Antagonists; Androstenedione; Cyproterone; Cyproterone Acetate; Endometrial Hyperplasia; Estradiol; Estrone; Female; Gonadal Steroid Hormones; Humans; Testosterone | 1986 |